Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT04987424Active, not recruitingUnilateral Breast Cancer
-
NCT06179303RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma
-
NCT03909282RecruitingSurgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma (NORDIS)Ductal Breast Carcinoma in Situ
-
NCT04022772CompletedBreast Carcinoma | Recurrent Breast Carcinoma | Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma
-
NCT04929301CompletedPregnancy Related | Breast Feeding | Milk Expression, Breast
-
NCT07551765Not yet recruitingTriple Negative Breast Cancer (TNBC), Early Setting
-
NCT07426913RecruitingBreast Cancer | Virtual Reality | Anthracycline Related Cardiotoxicity in Breast Cancer | Trastuzumab
-
NCT07365267RecruitingBreast Cancer | Breast Reconstruction After Mastectomy | 3D-Printed Biodegradable Biological Mesh
-
NCT07130383RecruitingAdvanced Breast Cancer | Advanced Malignant Solid Tumor
-
NCT06913244RecruitingLong-Term Multidisciplinary Physiotherapy for Breast Cancer Survivors: A Randomized Controlled TrialBreast Cancer | Breast Cancer Female
-
NCT06483477RecruitingBreast Cancer Female
-
-
NCT06212414RecruitingBreast Cancer Female
-
NCT05983107RecruitingTargeted Therapy | HR+/HER2- Advanced Breast Cancer
-
NCT05890287RecruitingHR Positive HER2 Negative Advanced Breast Cancer
-
NCT05334459Recruiting
-
NCT05018676RecruitingBreast Cancer With Low Expression of HER2
-
NCT04282031RecruitingAdvanced Solid Tumor | HR+/HER2- Breast Cancer
-
NCT04796324TerminatedMetastatic Breast Cancer
-
NCT04495309Completed
-
NCT04343820Completed
-
NCT05957042Withdrawn
-
-
NCT06695039Completed
-
NCT07154771Active, not recruitingBreast Surgery | Breast Cancer | Lymphedema
-
NCT01315106TerminatedBreast Cancer | Metastatic Breast Cancer
-
NCT06672380Completed
-
NCT05331807CompletedBreast Cancer Female
-
NCT03442504Active, not recruiting
-
NCT05065411Terminated
-
NCT04974567Active, not recruitingBreast Cancer | Breast Cancer Female | Tear
-
-
NCT04818359Active, not recruitingBreast Cancer Survivors
-
NCT03917082Active, not recruitingBreast Cancer Female | Hormone Receptor Positive Tumor
-
NCT05853432Completed
-
NCT05743023Active, not recruiting
-
NCT05576389Enrolling by invitationGermline BRCA-mutated HER2-negative Breast Cancer
-
NCT04741503CompletedOncology | Breast Cancer Screening | Mammography | Preventative Medicine
-
NCT01002014CompletedBreast Cancer | Breast Reconstruction | Cosmesis
-
NCT01506609Completed
-
NCT03163316Completed
-
NCT02687490CompletedMetastatic Breast Cancer
-
NCT03640819CompletedBreast Cancer | Sentinel Lymph Node | Tattoo; Pigmentation | Axilla; Breast
-
NCT02091765CompletedSexual Dysfunction | Breast Cancer Survivors | Intimacy Problems
-
NCT01876251Terminated
-
NCT03831308UnknownBreast Cancer Female
-
NCT01185509TerminatedBreast Cancer | Metastatic Breast Cancer
-
NCT00728949Completed
-
NCT01741883UnknownFemale Breast Cancer